Why Australia is emerging as an innovation hub for Bayer radiology

MedTech & Diagnostics News: Over the past decade, the field of medical imaging has undergone remarkable advancements fuelled by technology, opening up new possibilities for patient diagnosis and monitoring. In an intriguing interview, Michael Grimm, Country Group Head of Bayer Radiology ANZ & South Asia and Managing Director of Imaxeon (a subsidiary company of Bayer), joined Health Industry Hub to shed light on the dynamic landscape of radiology and its impact on patient care.

Australia has emerged as a leading innovation hub for Bayer radiology, thanks to its highly skilled workforce and innovation spirit. With local operations playing a crucial role in developing new technologies and manufacturing medical imaging devices, Australia has become a key contributor to Bayer’s global radiology business.

The discussion further delved into the key trends and exciting transformations shaping the future of radiology, driven by advancements in AI. These developments hold the promise of providing more efficient and accurate patient care, making radiology an indispensable cornerstone of modern healthcare.

Reimagining healthcare across the entire patient journey: Health Industry Hub^TM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.